Publicacions destacades

Clinical characterisation of patients in the post-acute stage of anti-NMDA receptor encephalitis: a prospective cohort study and comparison with patients with schizophrenia spectrum disorders

Guasp, M; Rosa-Justicia, M; Muñoz-Lopetegi, A; Martínez-Hernández, E; Armangué, T;

(...)

Sánchez-Valle, R; Santamaria, J; Compte, A; Castro-Fornielest, J; Dalmau, J.

Referència:
Lancet Neurology 2022.
Dynamics and Predictors of Cognitive Impairment along the Disease Course in Multiple Sclerosis

Lopez-Soley, Elisabet; Martinez-Heras, Eloy; Andorra, Magi; Solanes, Aleix; Radua, Joaquim;

(...)

Martinez-Lapiscina, Elena H; Villoslada, Pablo; Saiz, Albert; Solana, Elisabeth; Llufriu, Sara.

Referència:
J Pers Med 2021.
Oligoclonal IgM bands in the cerebrospinal fluid of patients with relapsing MS to inform long-term MS disability

Capuano, R; Zubizarreta, I; Alba-Arbalat, S; Sepulveda, M; Sola-Valls, N;

(...)

Llufriu, S; Fernández-Velasco, JI; Villar, LM; Gallo, A; Bisecco, A.

Referència:
Multiple Sclerosis Journal 2021.
Regional grey matter microstructural changes and volume loss according to disease duration in multiple sclerosis patients

Solana, E; Martinez-Heras, E; Lopez-Soley, E; Sola-Valls, N; Montejo, C;

(...)

Vilaplana, E; Fortea, J; Radua, J; Berenguer, J; Prados, F.

Referència:
Scientific Reports 2021.
Incidence and Impact of COVID-19 in MS: A Survey From a Barcelona MS Unit

Sepúlveda, M; Llufriu, S; Martínez-Hernández, E; Artola, M; Hernando, A;

(...)

Saiz, A; Català, M; Prats, C; Aldea, M; Graus, F.

Referència:
Neurology-Neuroimmunology & Neuroinflammation 2021.
Retinal and brain damage during multiple sclerosis course: inflammatory activity is a key factor in the first 5 years

Pulido-Valdeolivas, Irene; Andorra, Magi; Gomez-Andres, David; Nakamura, Kunio; Alba-Arbalat, Salut;

(...)

Camos-Carreras, Anna; Sanchez-Dalmau, Bernardo; Villoslada, Pablo; Saiz, Albert; Martinez-Lapiscina, Elena H.

Referència:
Scientific Reports 2020.
Characterization of multiple sclerosis lesions with distinct clinical correlates through quantitative diffusion MRI

Martinez-Heras, Eloy; Solana, Elisabeth; Prados, Ferran; Andorra, Magi; Solanes, Aleix;

(...)

Sepulveda, Maria; Blanco, Yolanda; Saiz, Albert; Radua, Joaquim; Llufriu, Sara.

Referència:
Neuroimage-Clinical 2020.
Late-onset neuromyelitis optica spectrum disorder: The importance of autoantibody serostatus

Sepulveda, M; Delgado-García, G; Blanco, Y; Sola-Valls, N; Martinez-Lapiscina, EH;

(...)

Llufriu, S; Dalmau, J; Graus, F; Saiz, A; Ruiz-García, R.

Referència:
Neurology-Neuroimmunology & Neuroinflammation 2019.
Immune tolerance in multiple sclerosis and neuromyelitis optica with peptide-loaded tolerogenic dendritic cells in a phase 1b trial

Zubizarreta, Irati; Florez-Grau, Georgina; Vila, Gemma; Cabezon, Raquel; Espana, Carolina;

(...)

Lozano, Miquel; Blanco, Yolanda; Steinman, Lawrence; Benitez-Ribas, Daniel; Villoslada, Pablo.

Referència:
Proceedings Of The National Academy Of Sciences Of The United States Of America 2019.
Assessing Biological and Methodological Aspects of Brain Volume Loss in Multiple Sclerosis.

Andorra, Magi; Nakamura, Kunio; Lampert, Erika J; Pulido-Valdeolivas, Irene; Zubizarreta, Irati;

(...)

Tercero-Uribe, Ana; Blanco, Yolanda; Saiz, Albert; Villoslada, Pablo; Martinez-Lapiscina, Elena H.

Referència:
Jama Neurology 2018.